Molecule Details
| InChIKey | MWCOYDBWBFJQIT-UHFFFAOYSA-N |
|---|---|
| Compound Name | N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-6-methyl-5-(1-morpholin-4-ylethyl)-1-(1H-pyrazol-5-yl)indolizine-7-carboxamide |
| Canonical SMILES | COc1cc(C)[nH]c(=O)c1CNC(=O)c1cc2c(-c3ccn[nH]3)ccn2c(C(C)N2CCOCC2)c1C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.67 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| O75530 | EED | Homo sapiens | Human | PF00400 | 8.7 | IC50 | ChEMBL |
| Q09028 | RBBP4 | Homo sapiens | Human | PF12265 PF00400 | 8.7 | IC50 | ChEMBL |
| Q15022 | SUZ12 | Homo sapiens | Human | PF09733 PF23320 | 8.7 | IC50 | ChEMBL |
| Q15910 | EZH2 | Homo sapiens | Human | PF21358 PF11616 PF18118 PF18264 PF00856 | 8.7 | IC50 | ChEMBL;BindingDB |
| Q6ZN18 | AEBP2 | Homo sapiens | Human | PF26014 | 8.7 | IC50 | ChEMBL |